These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11454011)

  • 1. Hepatic lipase gene variation is related to coronary reactivity in healthy young men.
    Fan Y; Laaksonen R; Janatuinen T; Vesalainen R; Nuutila P; Koivula T; Knuuti J; Lehtimäki T
    Eur J Clin Invest; 2001 Jul; 31(7):574-80. PubMed ID: 11454011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of hepatic lipase C-480T polymorphism on coronary flow reserve in young men is independent of the plasma cholesterol level.
    Fan YM; Laaksonen R; Janatuinen T; Vesalainen R; Laine H; Raitakari OT; Nuutila P; Knuuti J; Rontu R; Lehtimäki T
    Atherosclerosis; 2006 Oct; 188(2):391-7. PubMed ID: 16330034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase gene variation and coronary flow reserve in young healthy men.
    Mäkelä R; Laaksonen R; Janatuinen T; Vesalainen R; Nuutila P; Jaakkola O; Knuuti J; Lehtimäki T
    J Biomed Sci; 2004; 11(1):59-64. PubMed ID: 14730210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatic lipase gene C-480T polymorphism in the development of early coronary atherosclerosis: the Helsinki Sudden Death Study.
    Fan YM; Lehtimäki T; Rontu R; Ilveskoski E; Goebeler S; Kajander O; Mikkelsson J; Viiri LE; Perola M; Karhunen PJ
    Eur J Clin Invest; 2007 Jun; 37(6):472-7. PubMed ID: 17537154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen receptor gene variation is a determinant of coronary reactivity in healthy young men.
    Lehtimäki T; Laaksonen R; Mattila KM; Janatuinen T; Vesalainen R; Nuutila P; Laakso J; Jaakkola O; Koivula T; Knuuti J
    Eur J Clin Invest; 2002 Jun; 32(6):400-4. PubMed ID: 12059984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography.
    Dayanikli F; Grambow D; Muzik O; Mosca L; Rubenfire M; Schwaiger M
    Circulation; 1994 Aug; 90(2):808-17. PubMed ID: 8044952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment.
    Zambon A; Deeb SS; Brown BG; Hokanson JE; Brunzell JD
    Circulation; 2001 Feb; 103(6):792-8. PubMed ID: 11171785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The -250G-->A polymorphism in the human hepatic lipase gene promoter affects blood lipids in Chinese.
    Zhao S; Xie X; Nie S
    Clin Chim Acta; 2006 Mar; 365(1-2):149-52. PubMed ID: 16153627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients.
    Jansen H; Verhoeven AJ; Weeks L; Kastelein JJ; Halley DJ; van den Ouweland A; Jukema JW; Seidell JC; Birkenhäger JC
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2837-42. PubMed ID: 9409263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low hepatic lipase activity is a novel risk factor for coronary artery disease.
    Dugi KA; Brandauer K; Schmidt N; Nau B; Schneider JG; Mentz S; Keiper T; Schaefer JR; Meissner C; Kather H; Bahner ML; Fiehn W; Kreuzer J
    Circulation; 2001 Dec; 104(25):3057-62. PubMed ID: 11748100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic lipase C-480T genotype-dependent benefit from long-term hormone replacement therapy for atherosclerosis progression in postmenopausal women.
    Fan YM; Dastidar P; Jokela H; Punnonen R; Lehtimäki T
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3786-92. PubMed ID: 15755868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between coronary flow reserve and development of coronary calcifications: a follow-up study for 11 years in healthy young men.
    Uusitalo V; Saraste A; Kajander S; Luotolahti M; Wendelin-Saarenhovi M; Sundell J; Raitakari O; Knuuti J
    Eur Heart J Cardiovasc Imaging; 2013 Aug; 14(8):812-8. PubMed ID: 23264601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent association between hepatic lipase gene C-480T polymorphism and the risk of pre-hospital sudden cardiac death: the Helsinki Sudden Death Study.
    Fan YM; Lehtimäki T; Rontu R; Ilveskoski E; Goebeler S; Kajander O; Mikkelsson J; Perola M; Karhunen PJ
    Atherosclerosis; 2007 Jun; 192(2):421-7. PubMed ID: 16793047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese.
    Tan KC; Shiu SW; Chu BY
    Atherosclerosis; 2001 Jul; 157(1):233-9. PubMed ID: 11427226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men.
    Laine H; Nuutila P; Luotolahti M; Meyer C; Elomaa T; Koskinen P; Rönnemaa T; Knuuti J
    J Clin Endocrinol Metab; 2000 May; 85(5):1868-73. PubMed ID: 10843167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study.
    Lindi V; Schwab U; Louheranta A; Vessby B; Hermansen K; Tapsell L; Riccardi G; Rivellese AA; Laakso M; Uusitupa MI;
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):88-95. PubMed ID: 17327141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype.
    Ilveskoski E; Lehtimäki T; Laaksonen R; Janatuinen T; Vesalainen R; Nuutila P; Laippala P; Karhunen PJ; Knuuti J
    Scand J Clin Lab Invest; 2007; 67(7):723-34. PubMed ID: 17852827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between a novel polymorphism of hepatic lipase gene and coronary artery disease.
    Su ZG; Zhang SZ; Hou YP; Zhang L; Huang DJ; Liao LC; Xiao CY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):780-5. PubMed ID: 12417924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease.
    McCaskie PA; Cadby G; Hung J; McQuillan BM; Chapman CM; Carter KW; Thompson PL; Palmer LJ; Beilby JP
    Clin Genet; 2006 Aug; 70(2):114-21. PubMed ID: 16879193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.